bioAffinity Technologies (BIAF) Change in Inventory (2022 - 2026)

bioAffinity Technologies has disclosed Change in Inventory across 5 years of filings, most recently posting $24339.0 for Q1 2026.

• In Q1 2026, Change in Inventory rose 117.82% year-over-year to $24339.0; the TTM figure through Mar 2026 stood at $39105.0 (up 33.49% YoY), while the FY2025 annual figure was $25940.0, up 184.31% from the prior year.
• Change in Inventory improved to $24339.0 in Q1 2026, from $18314.0 in the prior quarter.
• Over the last five years, Change in Inventory for BIAF reached as high as $24339.0 in Q1 2026 and fell as low as -$8997.0 in Q1 2024.
• The 5-year median for Change in Inventory is $2245.0 (2024), against an average of $4581.6.
• Annual changes were most pronounced in 2023 — Change in Inventory soared 5000.57% — and 2024, when it sank 2182.38%.
• A 5-year view of Change in Inventory shows it stood at -$175.0 in 2022, then soared by 5000.57% to $8576.0 in 2023, then slumped by 73.82% to $2245.0 in 2024, then surged by 715.77% to $18314.0 in 2025, then jumped by 32.9% to $24339.0 in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $24339.0, $18314.0, and -$8737.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.